News

Filter

Current filters:

Nycomed

1 to 9 of 342 results

Takeda Pharma considering expansion in Russia and other BRIC countries

25-10-2012

Amid the falling dynamics in the European Union and the USA, Japan's largest drugmaker Takeda Pharmaceutical…

EuropeGlobalMarkets & MarketingNycomedPharmaceuticalTakeda Pharmaceuticals

Takeda completes 75 million-euro Russian pharmaceutical production plant

11-09-2012

Takeda Pharmaceutical International GmbH said this morning that it has completed the construction at…

EuropeNycomedPharmaceuticalProductionTakeda Pharmaceuticals

Nycomed debuts Omnaris nasal spray in the UAE

14-03-2012

Nycomed, a subsidiary of Japanese drug major Takeda Pharmaceuticals (TYO: 4502), said yesterday that…

Markets & MarketingNycomedOmnarisPharmaceuticalRespiratory and PulmonaryRest of the WorldTakeda Pharmaceuticals

EU Commission finds no evidence against AstraZeneca and Nycomed

02-03-2012

The European Commission said yesterday that it has ceased its antitrust investigation into the pharmaceutical…

AstraZenecaEuropeLegalNycomedPatentsPharmaceuticalRegulationTakeda Pharmaceuticals

Costs take toll on earnings from Japan’s Takeda

01-02-2012

Japan’s largest drugmaker, Takeda Pharmaceutical (TSE: 4502), yesterday released consolidated results…

FinancialNycomedPharmaceuticalTakeda Pharmaceuticals

Takeda cuts 2,800 jobs as it assimilates Nycomed

19-01-2012

Japan’s largest drugmaker Takeda Pharmaceutical (TSE: 4502) yesterday announced strategic measures…

FinancialManagementNycomedPharmaceuticalResearchTakeda Pharmaceuticals

Takeda ends Daxas co-promotion with MSD; Actos law suits

03-01-2012

Japan’s largest drugmaker, Takeda Pharmaceuticals (TYO: 4502) says that it has reached a mutual…

ActosDaxasDiabetesLegalLicensingMerck & CoNycomedPharmaceuticalRespiratory and PulmonaryTakeda Pharmaceuticals

1 to 9 of 342 results

Back to top